Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Cardinal Health logo

Cardinal Health Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Cardinal Health holds $56.7B in total assets. Shareholders' equity is -$2.8B against $8.9B in total debt. Cash and equivalents total $3.9B. The current ratio is 0.906 and debt-to-equity is 4.09. Based on the Q1 2026 filing.

Total Assets$56.7BTotal Stockholders Equity-$2.8BLong Term Debt$8.9BCash And Equivalents$3.9BTotal Current Assets$38.1BTotal Current Liabilities$42.0B
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$51.8B
P/E Ratio33.31
ROE37.39%

Current Liabilities

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Accounts payable$31.3B$32.8B$34.7B$36.9B$39B$37.8B
Current Portion of Long-Term Debt and Finance Lease Obligations$544M$543M$550M$52M$680M$671M
Total current liabilities$35.2B$36.7B$38.9B$40.3B$43.3B$42B

Current Assets

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Accounts receivable, net$12.4B$12.7B$13.2B$13.8B$13.7B$13.6B
Assets held for sale$50M$47M$12M$13M$0$0
Cash and cash equivalents$3.8B$3.3B$3.9B$4.6B$2.8B$3.9B
Other current assets$2.6B$2.4B$2.4B$2.6B$2.7B$2.5B
Inventories$16.9B$16.2B$16.8B$17.6B$20.1B$18B
Total current assets$35.8B$34.6B$36.4B$38.5B$39.2B$38.1B

Equity

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Accumulated other comprehensive income (loss)-$180M-$176M-$155M-$159M-$153M-$161M
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively$2.9B$2.9B$3B$2.7B$2.8B$2.8B
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0$0$0$0$0$0
Treasury Stock, Value$6B$6.4B$6.4B$6.6B$7B$7.2B
Retained earnings$283M$664M$783M$1.1B$1.5B$1.7B
Total liabilities and stockholders' equity$47B$49.9B$53.1B$55.2B$58.1B$56.7B
Total stockholders' equity-$3B-$2.9B-$2.8B-$2.9B-$2.9B-$2.8B

Non-Current Assets

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Deferred Tax Assets and Other Non-Current Assets$1.3B$1.6B$1.7B$1.8B$2B$2B
Goodwill$5.5B$8.9B$9.7B$9.7B$11.6B$11.4B
Goodwill and Intangible Assets, Net$7.4B$11B$12.2B$12.1B$14B$13.7B
Indefinite-Lived Intangible Assets$12M$13M$13M$14M$14M$25M
Indefinite-Lived Intangible Assets, Gross$12M$13M$13M$14M$14M$25M
Indefinite-Lived Research and Development Assets$12M$13M$13M$14M$14M$25M
Indefinite-Lived Trademarks$12M$13M$13M$14M$14M$25M
Intangible assets — net$1.9B$2.1B$2.5B$2.4B$2.4B$2.3B
Other intangible assets—net$1.9B$2.1B$2.5B$2.4B$2.4B$2.3B
Goodwill and intangible assets, net$7.4B$11B$12.2B$12.1B$14B$13.7B
Other non-current assets$1.3B$1.6B$1.7B$1.8B$2B$2B
Property and equipment, net$2.6B$2.7B$2.9B$2.8B$2.9B$2.9B
Software and Technology Licenses, Net$1.3B$1.6B$1.7B$1.8B$2B$2B
Total assets$47B$49.9B$53.1B$55.2B$58.1B$56.7B

Non-Current Liabilities

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Long-term debt$7.6B$7.7B$8.5B$9B$9B$8.9B
Long-Term Debt and Finance Lease Obligations$7.1B$7.1B$8B$9B$8.3B$8.2B
Hybrid debt$137M$175M$213M$218M$215M$203M

Other

MetricQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Carrying Amount of Long-Term and other Short-Term Borrowings$7.6B$7.7B$8.5B$9B$9B$8.9B
Common stock, shares authorized (in shares)755M755M755M755M755M755M
Common stock, shares issued (in shares)271M271M271M271M271M271M
Deferred Tax and Other Liabilities, Noncurrent$7.6B$8B$8.9B$8.7B$9.1B$9.1B
Finite-Lived Intangible Assets, Accumulated Amortization$3.7B$3.7B$3.8B$3.9B$4B$4.1B
2028$240M$285M—$330M$349M$349M
2030$208M$249M—$284M$306M$306M
Remainder of 2026$144M$82M—$269M$193M$97M
2027$267M$308M—$366M$382M$382M
2029$213M$256M—$307M$327M$327M
Gross Carrying Amount$5.6B$5.8B$6.3B$6.3B$6.4B$6.4B
Trademarks$12M$13M$13M$14M$14M$25M
Indefinite- lived intangible impairment$5.6B$5.9B$6.3B$6.3B$6.4B$6.4B
Long-Term Debt and Lease Obligation$7.1B$7.1B$8B$9B$8.3B$8.2B
Less: current maturities$544M$543M$550M$52M$680M$671M
2028$545M$548M—$1.9B$1.9B$1.9B
2029$1.9B$1.9B—$837M$839M$740M
2029$658M$663M—$766M$766M$768M
2030$21M$27M—$674M$674M$676M
Thereafter$4.5B$4.6B—$4.9B$4.8B$4.8B
2027$24M$12M—$42M$27M$14M
Loss Contingency Estimate Of Possible Loss—————$160M
Noncontrolling interests in subsidiaries$70M$1.1B$147M$148M$184M$160M
Other accrued liabilities$3.4B$3.3B$3.6B$3.4B$3.6B$3.5B
Preferred Stock, Shares Authorized500K500K500K500K500K500K
Preferred Stock, Shares Issued000000
Restructuring Reserve$75M$82M$79M$71M$76M$73M
Incentive stock program, shares reserved for future grants (in shares)—15M——16M16M
Total Long-Term and Short-Term Obligations$7.6B$7.7B$8.5B—$9B$8.9B
Treasury stock, shares (in shares)29M32M32M33M35M36M
Unrecognized tax benefits$924M$890M$879M$894M$903M$906M
Penalties and interest accrued on unrecognized tax benefits$74M$64M$65M$70M$77M$72M
Amount that if recognized, would affect the effective tax rate or regulatory liability$860M$865M$871M$877M$877M$880M
Remainder of Fiscal Year 2024$144M$82M—$269M$193M$97M